Evidence for Fas counter attack in vivo from a study of colorectal cancer.

  • Authors:
    • E Arbuckle
    • N E Langlois
    • O Eremin
    • S D Heys
  • View Affiliations

  • Published online on: January 1, 2000     https://doi.org/10.3892/or.7.1.45
  • Pages: 45-52
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Peritumoural cytotoxic lymphocytic infiltrates in colorectal carcinoma may attack tumour cells by expressing Fas ligand and inducing tumour cell apoptosis. However, tumours may mount a by down regulating their Fas pathway and expressing Fas ligand themselves to induce apoptosis of lymphocytes. This study used immunohistochemistry to demonstrate the presence of CD8+ lymphocytes and Fas ligand. The score of CD8+ peritumoural lymphocytes was negatively correlated with the Fas ligand score of the tumour. The results provide evidence for the Fas theory, but further work would be required to determine if this is a significant factor in the tumour-host interaction.

Related Articles

Journal Cover

Jan-Feb 2000
Volume 7 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Arbuckle E, Langlois N, Eremin O and Heys S: Evidence for Fas counter attack in vivo from a study of colorectal cancer.. Oncol Rep 7: 45-52, 2000
APA
Arbuckle, E., Langlois, N., Eremin, O., & Heys, S. (2000). Evidence for Fas counter attack in vivo from a study of colorectal cancer.. Oncology Reports, 7, 45-52. https://doi.org/10.3892/or.7.1.45
MLA
Arbuckle, E., Langlois, N., Eremin, O., Heys, S."Evidence for Fas counter attack in vivo from a study of colorectal cancer.". Oncology Reports 7.1 (2000): 45-52.
Chicago
Arbuckle, E., Langlois, N., Eremin, O., Heys, S."Evidence for Fas counter attack in vivo from a study of colorectal cancer.". Oncology Reports 7, no. 1 (2000): 45-52. https://doi.org/10.3892/or.7.1.45